Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Otolaryngeal Cancer × Ketamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 4 Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain, Postoperative 2 Agnosia 2 Acute Pain 2 Rectal Neoplasms 1 Prostatic Neoplasms 1 Otolaryngeal Cancer 1 Lymphoma, Follicular 1 Ileus 1 Gastrointestinal Neoplasms 1 Emergence Delirium 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Colonic Neoplasms 1 Anxiety Disorders 1

Interventions

Saline Solution 1 Ketamine 1 Electroencephalography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03040024 2021-07-08

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

Emory University

Phase 4 Terminated

71 enrolled 17 charts

Otolaryngeal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡